SCHEMBL26540428

SCHEMBL26540428

CC(C)C(=O)c1cc(COC2CC2)nn1C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 12/20 0.39
CCNE1 P24864 11/20 0.39
GSK3B P49841 5/20 0.39
CDK1 P06493 1/20 0.39
CDK4 P11802 1/20 0.39
CCNA2 P20248 1/20 0.39
CCND1 P24385 1/20 0.39
CDK9 P50750 1/20 0.39
CDK6 Q00534 1/20 0.39
SMYD3 Q9H7B4 1/20 0.38
GAA P10253 1/20 0.35
ALDH1A1 P00352 1/20 0.35
CHRM3 P20309 1/20 0.33
MEN1 O00255 1/20 0.32
POLB P06746 1/20 0.32
KMT2A Q03164 1/20 0.32
LNPEP Q9UIQ6 1/20 0.32
PSMB8 P28062 1/20 0.32
PSMB9 P28065 1/20 0.32
PSMB5 P28074 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26105967 0.85 KDM4E (0.43) CDK2CCNE1GSK3BCDK1CDK4
SCHEMBL26540318 0.81 CDK2 (0.40) CDK2CCNE1GSK3BCDK1CDK4
SCHEMBL26105035 0.81 FAAH (0.44) CDK2CCNE1GSK3BCDK1CDK4
SCHEMBL31206739 0.75 KDM4E (0.31) SMYD3
SCHEMBL17452576 0.71 PSMB8 (0.49) KMT2APSMB8PSMB9PSMB5
SCHEMBL8014330 0.68 SMN1; SMN2 (0.43) GAAALDH1A1MEN1POLBKMT2A
SCHEMBL26540840 0.67 CCNE1 (0.35) CDK2CCNE1GSK3BALDH1A1MEN1
SCHEMBL24630337 0.66 KDM4E (0.36) GAAALDH1A1MEN1KMT2A
SCHEMBL26964715 0.66 KDM4E (0.44) CDK2CCNE1GSK3BCDK1CDK4
SCHEMBL26964748 0.65 RAB9A (0.45) SMYD3ALDH1A1MEN1POLBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023072096-A1 TETRAHYDROFURAN-CONTAINING POLYCYCLIC DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PREPARATION METHOD THEREFOR AND USE THEREOF 优领医药科技(香港)有限公司 2023-05-04 WO disclosed